West Pharmaceutical Services, Inc.
WSTLast close · Oct 16, 2026384.02+1.00 (+0.26%)
Market cap$27.0B
4 firms' latest targets, last 90 days: median $420.00 ($400.00–$440.00), 9% above the last close.
Price and published targets
Each firm's latest target
| Date | Firm | Target | Change | Vs price now |
|---|---|---|---|---|
| 2026-10-07 | Barclays | $440.00 | ▲ 10% | +15% |
| 2026-09-22 | Morgan Stanley | $400.00 | ▲ 10% | +4% |
| 2026-09-09 | UBS | $415.00 | ▲ 22% | +8% |
| 2026-07-27 | Evercore ISI | $425.00 | ▲ 4% | +11% |
Consensus estimates
| FY | Revenue | YoY | EPS | YoY | Revenue range | EPS range | Analysts |
|---|---|---|---|---|---|---|---|
| 2023reported | $2.9B | +2% | $7.88 | +2% | est. $3.0B+0% | est. $8.01 | 6 |
| 2024reported | $2.9B | -2% | $6.69 | -15% | est. $2.9B+0% | est. $6.63 | 8 |
| 2025reported | $3.1B | +6% | $6.79 | +1% | est. $3.1B+0% | est. $7.10 | 11 |
| 2026 | $3.4B | +10% | $8.98 | +27% | $3.3B–$3.4B | $8.88–$9.05 | 13 |
| 2027 | $3.6B | +6% | $10.03 | +12% | $3.5B–$3.6B | $9.50–$10.34 | 13 |
| 2028 | $3.9B | +7% | $11.46 | +14% | $3.7B–$4.0B | $10.43–$12.61 | 10 |
| 2029 | $4.2B | +10% | $12.97 | +13% | $4.2B–$4.3B | $12.70–$13.26 | 5 |
| 2030 | $4.5B | +6% | $14.01 | +8% | $4.4B–$4.6B | $13.72–$14.32 | 5 |
Targets, grades and estimates are quoted from third parties (via Financial Modeling Prep) and are theirs, not ours; each target links to the report it was published in. A firm counts once, at its latest target or grade.